Sep 06, 2016 16:00 pm UTC| Business
PASCAGOULA, Miss., Sept. 06, 2016 -- Huntington Ingalls Industries (NYSE:HII) is showcasing Dianna Genton, a naval architect at its Ingalls Shipbuilding division, as the company’s latest brand ambassador for its new...
Western Growers Establishes Strategic Alliance With JLT to Provide Global Insurance Solutions
Sep 06, 2016 16:00 pm UTC| Business
New alliance expands Western Growers’ worldwide insurance offerings to food and agribusiness industry LOS ANGELES, Sept. 06, 2016 -- Western Growers Insurance Services is expanding its global reach through a new...
Sep 06, 2016 15:57 pm UTC| Business
IRVINE, Calif., Sept. 06, 2016 -- Autobytel Inc. (Nasdaq:ABTL), a leading provider of online automotive services connecting consumers with dealers, recently shared highlights of the effectiveness of its Autobytel Direct...
Federal-Mogul Enters into Definitive Merger Agreement with Icahn Enterprises L.P.
Sep 06, 2016 15:45 pm UTC| Business
SOUTHFIELD, Mich. and NEW YORK, Sept. 06, 2016 -- Federal-Mogul Holdings Corporation (NASDAQ:FDML) (“Federal-Mogul”) and Icahn Enterprises L.P. (NASDAQ:IEP) (“Icahn Enterprises”) today announced that Federal-Mogul had...
Fulgent Genetics Files Registration Statement for Initial Public Offering
Sep 06, 2016 15:42 pm UTC| Business
TEMPLE CITY, Calif., Sept. 06, 2016 -- Fulgent Genetics, Inc. announced today that it has filed a registration statement with the Securities and Exchange Commission for a proposed initial public offering of its common...
Responsible Fans Rewarded at Darlington Raceway
Sep 06, 2016 15:40 pm UTC| Business
Darlington, SC, Sept. 06, 2016 -- Responsible fans earned valuable rewards at the Bojangles’ Southern 500 on September 4, 2016. The race marks the first time Darlington Raceway, Americrown and Techniques for...
SteadyMed to Present at the 18th Annual Rodman & Renshaw Global Investment Conference
Sep 06, 2016 15:37 pm UTC| Business
SAN RAMON, Calif., Sept. 06, 2016 -- SteadyMed Ltd. (Nasdaq:STDY), a specialty pharmaceutical company focused on the development of drug product candidates to treat orphan and high-value diseases with unmet parenteral...